Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

(S)-(-)-OSU-6162 effective in monkey model of Parkinson's disease

Sep. 9, 1997

SB-204269, an anticonvulsant with a unique mechanism of action

Sep. 9, 1997

Copaxone approved in Canada

Sep. 9, 1997

Ethnic differences in codeine's efficacy/side effects

Sep. 9, 1997

Warner-Lambert/CoCensys develop neuroprotective agents

Sep. 9, 1997

Additional results for Bradycor in traumatic brain injury

Sep. 9, 1997

NK1 antagonist effective in rat model of focal cerebral ischemia

Sep. 9, 1997

Sleep-promoting effects of L-846 demonstrated in insomniac patients

Sep. 8, 1997

Aricept now available in Canada

Sep. 8, 1997

Cambridge NeuroScience moves CNS-5161 to clinical trials

Sep. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...